Location History:
- St. Louis, MO (US) (2019)
- Creve Coeur, MO (US) (2020)
Company Filing History:
2 out of 1,585 
1 out of 15,502 
Years Active: 2019-2020
Title: Hui Liu: Innovator in Sphingosine-1-Phosphate Receptor Research
Introduction
Hui Liu is a prominent inventor based in Creve Coeur, MO (US). She has made significant contributions to the field of biomedical research, particularly in the area of sphingosine-1-phosphate receptor (S1P1) and neurodegenerative diseases. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various health conditions.
Latest Patents
Hui Liu's latest patents include innovative compositions for binding sphingosine-1-phosphate receptor 1 (S1P1) and methods for imaging S1P1. These patents provide imaging agents that can be used for the detection of S1P1 associated diseases, disorders, and conditions. Additionally, her work on sulfur-containing compounds targeting the vesicular acetylcholine transporter (VAChT) offers new methods for detecting neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
Career Highlights
Throughout her career, Hui Liu has worked with esteemed institutions, including Washington University and the University of California. Her research has focused on developing therapeutic compositions and methods that address S1P1 associated diseases, showcasing her commitment to advancing medical science.
Collaborations
Hui Liu has collaborated with notable colleagues, including Zhude Tu and Adam Rosenberg. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Hui Liu's contributions to the field of biomedical research, particularly in the areas of S1P1 and neurodegenerative diseases, highlight her role as an influential inventor. Her patents and collaborations reflect her dedication to improving health outcomes through innovative solutions.